TABLE 1.
Demographic and immunologic characteristics of the study subjectsa
| Status of study subjects | Gender (no. of males/females) | Age (yr) | No. of lymphocytes/μl (× 1,000) | No. of CD4+ T cells/μl | % CD4+ T cells | No. of CD8+ T cells/μl | % CD8+ T cells | CD4/CD8 ratio | HIV-1 RNA log no. of copies/ml |
|---|---|---|---|---|---|---|---|---|---|
| HIV− | 16/3 | 43 (33-56) | 1.7 (1.4-2.0) | 835 (650-1,209) | 40 (37-48) | 580 (513-647) | 26 (23-30) | 1.6 (1.2-1.8) | |
| TxHIV+ | 44/0 | 50 (40-56) | 2.1 (1.8-2.4) | 497 (312-662) | 29 (20-35) | 802 (588-1,160) | 47 (39-55) | 0.6 (0.4-0.9) | <1.7 |
| EC | 15/0 | 51 (48-53) | 2.1 (1.7-2.4) | 690 (638-830) | 43 (35-49) | 693 (554-890) | 37 (32-42) | 1.1 (0.9-1.5) | <1.7 |
| vHIV+ | 39/2 | 48 (39-56) | 2.3 (1.6-2.8) | 447 (357-633) | 27 (20-33) | 901 (687-1,350) | 52 (44-60) | 0.5 (0.4-0.8) | 3.9 (3.6-4.8) |
a
Except for gender, numbers provided are median values, with interquartile ranges in parentheses. Tx, treated.